GT Biopharma Inc (GTBP)

[trader993]

Nonsense. Most biotech companies are in a similar situation and trade dollars.

$OXIS managed to get through phase 1 in a similar financial situation, see filings from 2014 and it´s possible they will find a partner and will continue.

You think a pharma stock with active FDA trial in phase 1/2 is only worth a $1.7m market cap? LOL
OXIS is massive undervalued!

The Estimated Primary Completion Date of $OXIS cancer drug in
FDA phase 1/2 is June 2017. Any positive update about this trial would move it up huge!

https://clinicaltrials.gov/ct2/show/study/NCT02370160?term=DT2219ARL&rank=2#contacts

"Estimated Enrollment: 44
Study Start Date: December 2015
Estimated Study Completion Date: June 2018
Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)"

If you research "DT2219ARL"and "pubmed",many peer review articles. Drug has huge potential, that´s a lot space from a $1,7m market cap if the drug has the potential to cure cancer!

And Oxis is in the process of acquiring more high potential drugs.